Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stomatitis × clazakizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomatitis 1 Head and Neck Neoplasms 1

Interventions

hydrated silica gel-based toothpaste 1 cobiprostone 1 clazakizumab 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Zinc Sulfate 1 Zinc 1 Tomography, Optical Coherence 1 Surveys and Questionnaires 1 Standard of Care 1 Spectrometry, Fluorescence 1 Saline Solution 1 Radiation 1 Mannitol 1 Lidocaine 1 Etanercept 1 Drug Therapy 1 Diphenhydramine 1 Dental Prophylaxis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

CSL Behring

Phase 2 Terminated

76 enrolled 25 charts

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡